Radioisotope Supply Chain and Pharma M&A Trends
An executive analysis of the radioisotope market, highlighting Eckert & Ziegler's dual-segment strategy, the capital-intensive nature of production, and the impact of recent M&A activity on supply chain resilience in radiopharmaceuticals.